Barriers and solutions to implementing metabolic risk assessment in a secondary mental health service

Australasian Psychiatry

Volumn 18, Issue 4, 2010, Pages 322-325

  Dunbar, Lucy ^a   Brandt, Theo ^b   Wheeler, Amanda ^a   Harrison, Jeff ^b  

^a WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Barriers; Community mental health; Metabolic risk assessment; Solutions

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; HEALTH PROGRAM; HUMAN; MEDICAL EDUCATION; MENTAL HEALTH ORGANIZATION; MENTAL HEALTH SERVICE; RISK ASSESSMENT; SEMI STRUCTURED INTERVIEW;

ADULT; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; HEALTH EDUCATION; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL DISORDERS; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 77954866329     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.3109/10398561003692571     Document Type: Article

References (13)

1. Dunbar L, Brandt T, Wheeler A, Harrison J, Condell W, Stoepker J. Implementing metabolic risk assessment in a secondary care mental health service. Australasian Psychiatry 2010; 18 : 318-321.
2. Barnes TRE, Paton C, Cavanagh MR, Hancock E, Taylor DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 2007; 33 : 1397-1403.
3. Hyland B, Judd F, Davidson S, Jolley D, Hocking B. Case managers'attitudes to the physical health of their patients. Australian and New Zealand Journal of Psychiatry 2003; 37 : 710-714.
4. Druss BG, Marcus SC, Campbell J et al. Medical services for clients in community mental health centers: results from a national survey. Psychiatric Services 2008; 59 : 917-920.
5. Wheeler A, Harrison J, Homes Z. Cardiovascular risk assessment and management in mental health clients: perceptions of mental health and general practitioners in New Zealand. Journal of Primary Health Care 2009; 1 : 11-19.
6. Boardman JB. Health access and integration for adults with serious and persistent mental illness. Families, Systems & Health: The Journal of Collaborative Family HealthCare 2006; 24 : 3-18.
7. Mackin P, Bishop DR, Watkinson HMO. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry 2007; 7 : 28.
8. Taylor D, Young C, Esop R, Paton C, Walwyn R. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. British Journal of Psychiatry 2004; 185 : 152-156.
9. Runcie O, Boilson M, Hamilton R. Monitoring weight and blood glucose in in-patients: how helpful is a protocol? Psychiatric Bulletin 2007; 31 : 88-91.
10. Barnes TRE, Paton C, Hancock E, Cavanagh MR, Taylor D, Lelliott P. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme. Acta Psychiatrica Scandinavica 2008; 118 : 26-33.
11. Newcomer JW, Nasrallah HA, McIntyre RS, Hennekens CH, Vogel-Scibilia S. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. CNS Spectrums 2008; 13 : 1-14.
12. Walter G, DeLaroche A, Soh N et al. Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry 2008; 16 : 253-262.
13. Nguyen D, Brakoulias V, Boyce P. An evaluation of monitoring practices in patients on second generation antipsychotics. Australasian Psychiatry 2009; 17 : 295-299.